Increased expression of TRAIL and its receptors on peripheral T-cells in type 1 diabetic patients

Iranian Journal of Immunology

Volumn 4, Issue 4, 2007, Pages 197-205

  Salehi, Eisa ^a   Vodjgani, Mohammad ^a,d   Massoud, Ahmad ^a   Keyhani, Abdolhosein ^a   Rajab, Asadollah ^b   Shafaghi, Behrooz ^c   Gheflati, Zahra ^a   Aboufazeli, Tahereh ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Iranian Diabetes Society   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

T cell; TRAIL; TRAIL receptors; Type I diabetes

Indexed keywords

MESSENGER RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ADOLESCENT; ADULT; ANALYTIC METHOD; ARTICLE; CELL ISOLATION; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PERIPHERAL T CELL LYMPHOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 37249018445     PISSN: 17351383     EISSN: 1735367X     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Cheung SS, Metzger DL, Wang X, Huang J, Tai J, Tingle AJ et al. Tumor necrosis factor-related apoptosis-inducing ligand and CD56 expression in patients with type 1 diabetes mellitus. Pancreas. 2005; 30:105-14.
2. Gillespie KM. Type 1 diabetes: pathogenesis and prevention. Cmaj. 2006; 175:165-70.
3. Kelly MA, Rayner ML, Mijovic CH, Barnett AH. Molecular aspects of type 1 diabetes. Mol Pathol. 2003; 56:1-10.
4. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity. 1995; 3:673-82.
5. MacFarlane M, Ahmad M, Srinivasula SM, Fernandes-Alnemri T, Cohen GM, Alnemri ES. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J Biol Chem. 1997; 272:25417-20.
6. Anel A, Bosque A, Naval J, Pineiro A, Larrad L, Alava MA et al. Apo2L/TRAIL and immune regulation. Front Biosci. 2007; 12:2074-84.
7. Zheng SJ, Chen YH. TRAIL, Bim, and thymic-negative selection. Immunol Res. 2003;28:295-301.
8. Schaefer U, Voloshanenko O, Willen D, Walczak H. TRAIL: a multifunctional cytokine. Front Biosci. 2007;12:3813-24.
9. Ou D, Metzger DL, Wang X, Huang J, Pozzilli P, Tingle AJ. TNF-related apoptosis-inducing ligand death pathway-mediated human beta-cell destruction. Diabetologia. 2002; 45:1678-88.
10. Lamhamedi-Cherradi SE, Zheng S, Tisch RM, Chen YH. Critical roles of tumor necrosis factor-related apoptosis-inducing ligand in type 1 diabetes. Diabetes. 2003; 52:2274-8.
11. Mi QS, Ly D, Lamhamedi-Cherradi SE, Salojin KV, Zhou L, Grattan M et al. Blockade of tumor necrosis factor-related apoptosis-inducing ligand exacerbates type 1 diabetes in NOD mice. Diabetes. 2003; 52:1967-75.
12. Fukuda M, Hamao A, Tanaka A, Kitada M, Suzuki S, Kusama K et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/APO2L) and its receptors expression in human squamous cell carcinoma of the oral cavity. Oncol Rep. 2003; 10:1113-9.
13. Matsuyama W, Yamamoto M, Higashimoto I, Oonakahara K, Watanabe M, Machida K et al. TNF-related apoptosis-inducing ligand is involved in neutropenia of systemic lupus erythematosus. Blood. 2004 ;104:184-91.
14. Kayagaki N, Yamaguchi N, Nakayama M, Kawasaki A, Akiba H, Okumura K et al. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity. J Immunol. 1999; 162:2639-47.
15. Sato K, Niessner A, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM. TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque. J Exp Med. 2006; 203:239-50.
16. Wendling U, Walczak H, Dorr J, Jaboci C, Weller M, Krammer PH et al. Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells. Cell Death Differ. 2000; 7:637-44.
17. Corazza N, Brumatti G, Schaer C, Cima I, Wasem C, Brunner T. TRAIL and immunity: more than a license to kill tumor cells. Cell Death Differ. 2004; 11:122-5.
18. Ehrlich S, Infante-Duarte C, Seeger B, Zipp F. Regulation of soluble and surface-bound TRAIL in human T cells, B cells, and monocytes. Cytokine. 2003; 24:244-53.
19. Lunemann JD, Waiczies S, Ehrlich S, Wendling U, Seeger B, Kamradt T et al. Death ligand TRAIL induces no apoptosis but inhibits activation of human (auto)antigen-specific T cells.. J Immunol. 2002; 168:4881-8.
20. Song K, Chen Y, Goke R, Wilmen A, Seidel C, Goke A et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J Exp Med. 2000; 191:1095-104.
21. Corallini F, Celeghini C, Rizzardi C, Pandolfi A, Di Silvestre S, Vaccarezza M et al. Insulin down-regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro. J Cell Physiol. 2007; 212:89-95.
22. Okuyama S, Komatsuda A, Wakui H, Aiba N, Fujishima N, Iwamoto K et al. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome. Nephrol Dial Transplant . 2005; 20:539-44.
23. Arbour N, Rastikerdar E, McCrea E, Lapierre Y, Dorr J, Bar-Or A et al. Upregulation of TRAIL expression on human T lymphocytes by interferon beta and glatiramer acetate.. Mult Scler . 2005;11:652-7.
24. Tsokos GC, Tsokos M. The TRAIL to arthritis. J Clin Invest . 2003; 112:1315-7.
25. Hilliard B, Wilmen A, Seidel C, Liu TS, Goke R, Chen Y. Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis. J Immunol. 2001;166:1314-9.
26. Kayagaki N, Yamaguchi N, Nakayama M, Eto H, Okumura K, Yagita H. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs. J Exp Med. 1999;189:1451-60.
27. Chen GY, He JQ, Lu GC, Li MW, Xu CH, Fan WW et al. Association between TRAIL expression on peripheral blood lym-phocytes and liver damage in chronic hepatitis B. World J Gastroenterol . 2005; 11:4090-3.